Breast cancer: Image-guided biopsy might spare women from surgery

In a subgroup of patients, biopsy can reliably predict a complete response to neoadjuvant therapy, researchers say
Reuters Health Staff writers
female pathologist looking down microscope

Following neoadjuvant chemotherapy, image-guided vacuum-assisted biopsy can reliably identify a subgroup of patients with no residual breast disease, according to an analysis of pooled data from three continents.

In a paper in JAMA Surgery,  researchers note that with improvements in treatment, especially routine use of adjuvant radiotherapy and systemic therapy, certain patients may not benefit from surgery.